2010
Does Chocolate Intake During Pregnancy Reduce the Risks of Preeclampsia and Gestational Hypertension?
Saftlas AF, Triche EW, Beydoun H, Bracken MB. Does Chocolate Intake During Pregnancy Reduce the Risks of Preeclampsia and Gestational Hypertension? Annals Of Epidemiology 2010, 20: 584-591. PMID: 20609337, PMCID: PMC2901253, DOI: 10.1016/j.annepidem.2010.05.010.Peer-Reviewed Original ResearchConceptsGestational hypertensionRisk of preeclampsiaAdjusted odds ratioChocolate intakeReduced oddsCardiovascular disease risk markersChocolate consumptionAdverse pregnancy outcomesProspective cohort studyDisease risk markersPrenatal care practicesGH womenCohort studyNormotensive pregnanciesPregnancy outcomesBlood pressureWeeks' gestationThird trimesterHospital deliveryProspective studyRisk markersRisk factorsOdds ratioPrenatal recordsProtective effect
2008
73: Increased risk of maternal mortality from cardiovascular and non-cardiovascular causes following adverse pregnancy outcome in first delivery
Lykke J, Langhoff-Roos J, Triche E, Lockwood C, Paidas M. 73: Increased risk of maternal mortality from cardiovascular and non-cardiovascular causes following adverse pregnancy outcome in first delivery. American Journal Of Obstetrics And Gynecology 2008, 199: s33. DOI: 10.1016/j.ajog.2008.09.098.Peer-Reviewed Original ResearchAdverse pregnancy outcomesNon-cardiovascular causesPregnancy outcomesMaternal mortalityFirst deliveryMortality
2007
Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy.
Urban G, Vergani P, Tironi R, Ceruti P, Vertemati E, Sala F, Pogliani E, Triche EW, Lockwood CJ, Paidas MJ. Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy. International Journal Of Fertility And Women's Medicine 2007, 52: 59-67. PMID: 18320863.Peer-Reviewed Original ResearchMeSH KeywordsAdultAspirinCohort StudiesConfidence IntervalsDrug Therapy, CombinationFemaleFetal Growth RetardationFibrinolytic AgentsHeparin, Low-Molecular-WeightHumansInfant, NewbornLogistic ModelsOdds RatioParityPre-EclampsiaPregnancyRetrospective StudiesRisk FactorsSecondary PreventionWomen's HealthConceptsLow-dose aspirinAdverse pregnancy outcomesIntrauterine growth restrictionSevere preeclampsiaIndex pregnancyProphylactic low-dose aspirinRetrospective cohort studyIntrauterine growth retardationCohort of womenLogistic regression modelsAntithrombotic prophylaxisAntecedent pregnancyDose aspirinMultiparous patientsCohort studyMultiparous womenPregnancy outcomesWeight heparinGrowth restrictionOdds ratioPrevious historyGrowth retardationCombined treatmentLMWHPregnancy
2004
The Occurrence of Antibodies to Components of the Natural Coagulation Inhibitor System, Protein Z and Protheombin in Normal Pregnancy.
Ku D, Arkel Y, Paidas M, Triche E, Huang S, Musto J, Lockwood C. The Occurrence of Antibodies to Components of the Natural Coagulation Inhibitor System, Protein Z and Protheombin in Normal Pregnancy. Blood 2004, 104: 3995. DOI: 10.1182/blood.v104.11.3995.3995.Peer-Reviewed Original ResearchNon-pregnant controlsAnti-PC IgMAdverse pregnancy outcomesNormal pregnancyIgM antibodiesPS IgGOccurrence of antibodiesAnticardiolipin syndromeProthrombotic processesPregnancy outcomesAntibody levelsMost pregnanciesAutoimmune diseasesAntibody responseIgG antibodiesHemostatic balanceImmune responseTrimesterCoagulation factorsChronic responsesPregnancyIgMIgGGestationAntibodiesElevated sEPCR and PAI-1 Levels, but Not sThrombomodulin Levels in Normal Pregnancy.
Arkel Y, Paidas M, Ku D, Triche E, Lam X, Ku E, Lockwood C. Elevated sEPCR and PAI-1 Levels, but Not sThrombomodulin Levels in Normal Pregnancy. Blood 2004, 104: 3996. DOI: 10.1182/blood.v104.11.3996.3996.Peer-Reviewed Original ResearchEndothelial protein C receptorAdverse pregnancy outcomesPro-inflammatory cytokinesNormal pregnancyProtein C systemDecidual cellsEndothelial cellsProtein SEndometrial decidual cellsNon-pregnant controlsProtein C receptorCell surface proteinsPlasminogen activator inhibitorCell-surface thrombomodulinPregnancy outcomesProthrombotic statePlasma thrombomodulinNP patientsEC damageSurface proteinsControl of thrombosisSTM levelsTrimester samplesPregnancyFibrinolytic system